On ECHEMI
Home > Drugs > Carotid cavernous fistula
Carotid cavernous fistula
The direct communication between the carotid artery and the cavernous sinus is called carotid cavernous fistula (CCF), which is a relatively common neuro-ophthalmological syndrome. Due to special anatomical reasons, the cavernous sinus area is the site with the most arteriovenous fistulas in the body. More than 80% of patients first experience eye symptoms and signs, such as proptosis, congestion, and ocular motility disorders, and then visit an ophthalmologist. Sometimes due to lack of experience, it is misdiagnosed as an inflammatory pseudotumor, thyroid-related eye disease, conjunctivitis, scleritis, etc., which delays treatment and should attract special attention from ophthalmologists. Carotid cavernous fistula is a general name. Any branch of the common carotid artery, including the internal carotid artery, the external carotid artery, and the small blood vessels branching out from it, that directly or indirectly communicates with the cavernous sinus can be called a carotid cavernous fistula.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    It is more common in young men with a history of head trauma...
  • Related symptoms:

    Eye movement disorder red eyes visual impairment stiff neck hard skin on the back of the neck and shoulders
  • Concurrent disease:

Related Drugs
Aspirin enteric-coated tablets
Indication: Inhibit platelet aggregation, prevent thrombosis, treat and prevent transient ischemic attack, cerebral thrombosis, coronary heart disease, myocardial infarction, migraine, artificial heart valves, arteriovenous leakage and other post-operative thrombosis, thromboangiitis obliterans, etc.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.